Tennessee SB 522: Drugs, Prescription - As introduced, caps the total amount that a health insurance carrier can require a covered patient with diabetes to pay for a 30-day supply of insulin at no more than $100; caps the total price that a person who supplies prescription insulin drugs into or within this state for use by a patient with diabetes can charge for a 30-day supply of insulin at no more than $100. - Amends TCA Title 8; Title 53; Title 56, Chapter 7; Title 63 and Title 71, Chapter 5.

Status: No Action Taken (as of 2022-03-15)

State: Tennessee · Session: 112 · Bill: SB 522

Subjects: Drugs, Prescription

Sponsors: Briggs, Hodges

View Tennessee SB 522 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.